1215 Using nanoparticles as artificial antigen presenting ce…
Emerging
0
Citations0
Refs2023
Year
Search Works
Work Details
- DOI 10.1136/jitc-2023-sitc2023.1215
- OpenAlex ID W4388076197
- Type Conference-abstract
- Language EN
- Published 31 Oct 2023
- Pages A1340
- Source Regular and Young Investigator Award Abs…
- Countries 1
- Institutions 1
- Added 01 Nov 2023
- Updated 23 Aug 2026
External Links
MENU
0
1215 Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy
Conference-abstract 2023 EN Hybrid
Background CD4 T cells participate in anti-tumor immune responses, recruiting innate immune cells, direct lysis of tumor cells, and assisting CD8 activation. CD4 T cell-based adoptive cell transfer (ACT) therapies have clinical success across multiple cancer types, including metastatic melanoma and epithelial cancer.1 2 One of the challenges of CD4 T cell-based ACT therapy is finding methods to ex…
0
Citations
0
References
3
Authors
0.00
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Si-Sim Kang | Johns Hopkins University (US) | |
| 2 | Ariel Isser | Johns Hopkins University (US) | |
| 3 | Jonathan P. Schneck | Johns Hopkins University (US) |
Related Works
10Data: OpenAlex